Denali Therapeutics Inc. (DNLI)
11.76
-1.03 (-8.05%)
At close: Apr 04, 2025, 3:59 PM
11.82
0.47%
After-hours: Apr 04, 2025, 04:23 PM EDT
Denali Therapeutics Revenue
Denali Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending December 31, 2024, Denali Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
422
Market Cap
1.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 330.53M | +204.74% |
| Dec 31, 2022 | 108.46M | +122.90% |
| Dec 31, 2021 | 48.66M | -85.50% |
| Dec 31, 2020 | 335.66M | n/a |